🚀 VC round data is live in beta, check it out!
Medifast Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medifast and similar public comparables like Autoserver Co, Meb Corporation, IEVA Group, Vega Corp and more.
Medifast Overview
About Medifast
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Founded
1989
HQ
Employees
380
Website
Financials (LTM)
Market Cap
$120M
Medifast Financials
Medifast reported last 12-month revenue of $352M and EBITDA of $4M.
In the same LTM period, Medifast generated $249M in gross profit, $4M in EBITDA, and had net loss of ($20M).
Revenue (LTM)
Medifast P&L
In the most recent fiscal year, Medifast reported revenue of $386M and EBITDA of $8M.
Medifast expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $352M | XXX | $386M | XXX | XXX | XXX |
| Gross Profit | $249M | XXX | $275M | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 71% | XXX | XXX | XXX |
| EBITDA | $4M | XXX | $8M | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | (5%) | XXX | (4%) | XXX | XXX | XXX |
| Net Profit | ($20M) | XXX | ($19M) | XXX | XXX | XXX |
| Net Margin | (6%) | XXX | (5%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medifast Stock Performance
Medifast has current market cap of $120M.
Market Cap Evolution
Medifast's stock price is $10.92.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $120M | -0.4% | XXX | XXX | XXX | $-1.69 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedifast Valuation Multiples
Medifast trades at (0.1x) EV/Revenue multiple, and (9.4x) EV/EBITDA.
EV / Revenue (LTM)
Medifast Financial Valuation Multiples
As of April 21, 2026, Medifast has market cap of $120M.
Equity research analysts estimate Medifast's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medifast has a P/E ratio of (6.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $120M | XXX | $120M | XXX | XXX | XXX |
| EV (current) | ($36M) | XXX | ($36M) | XXX | XXX | XXX |
| EV/Revenue | (0.1x) | XXX | (0.1x) | XXX | XXX | XXX |
| EV/EBITDA | (9.4x) | XXX | (4.8x) | XXX | XXX | XXX |
| EV/EBIT | 2.1x | XXX | 2.5x | XXX | XXX | XXX |
| EV/Gross Profit | (0.1x) | XXX | (0.1x) | XXX | XXX | XXX |
| P/E | (6.1x) | XXX | (6.5x) | XXX | XXX | XXX |
| EV/FCF | 19.3x | XXX | (28.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medifast Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medifast Margins & Growth Rates
Medifast's revenue in the last 12 month declined by (24%).
Medifast's revenue per employee in the last FY averaged $1.0M, while opex per employee averaged $0.8M for the same period.
Medifast's rule of 40 is (31%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medifast's rule of X is (74%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Medifast Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | (24%) | XXX | (29%) | XXX | XXX | XXX |
| EBITDA Margin | 1% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | (286%) | XXX | (160%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (31%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (74%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medifast Public Comps
See public comps and valuation multiples for other Consumer E-commerce and Health & Beauty comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medifast | XXX | XXX | XXX | XXX | XXX | XXX |
| Autoserver Co | XXX | XXX | XXX | XXX | XXX | XXX |
| Meb Corporation | XXX | XXX | XXX | XXX | XXX | XXX |
| IEVA Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Vega Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| HKTV | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medifast M&A Activity
Medifast acquired XXX companies to date.
Last acquisition by Medifast was on XXXXXXXX, XXXXX. Medifast acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medifast
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedifast Investment Activity
Medifast invested in XXX companies to date.
Medifast made its latest investment on XXXXXXXX, XXXXX. Medifast invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medifast
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medifast
| When was Medifast founded? | Medifast was founded in 1989. |
| Where is Medifast headquartered? | Medifast is headquartered in United States. |
| How many employees does Medifast have? | As of today, Medifast has over 380 employees. |
| Who is the CEO of Medifast? | Medifast's CEO is Daniel R. Chard. |
| Is Medifast publicly listed? | Yes, Medifast is a public company listed on NYSE. |
| What is the stock symbol of Medifast? | Medifast trades under MED ticker. |
| When did Medifast go public? | Medifast went public in 1981. |
| Who are competitors of Medifast? | Medifast main competitors are Autoserver Co, Meb Corporation, IEVA Group, Vega Corp. |
| What is the current market cap of Medifast? | Medifast's current market cap is $120M. |
| What is the current revenue of Medifast? | Medifast's last 12 months revenue is $352M. |
| What is the current revenue growth of Medifast? | Medifast revenue growth (NTM/LTM) is (24%). |
| What is the current EV/Revenue multiple of Medifast? | Current revenue multiple of Medifast is (0.1x). |
| Is Medifast profitable? | Yes, Medifast is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medifast? | Medifast's last 12 months EBITDA is $4M. |
| What is Medifast's EBITDA margin? | Medifast's last 12 months EBITDA margin is 1%. |
| What is the current EV/EBITDA multiple of Medifast? | Current EBITDA multiple of Medifast is (9.4x). |
| What is the current FCF of Medifast? | Medifast's last 12 months FCF is ($2M). |
| What is Medifast's FCF margin? | Medifast's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of Medifast? | Current FCF multiple of Medifast is 19.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.